4//SEC Filing
LINK WILLIAM J PHD 4
Accession 0001819790-24-000102
CIK 0001819790other
Filed
Jun 24, 8:00 PM ET
Accepted
Jun 25, 6:25 PM ET
Size
7.2 KB
Accession
0001819790-24-000102
Insider Transaction Report
Form 4
LINK WILLIAM J PHD
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2024-06-24−3,350→ 0 total→ Common Stock (3,350 underlying) - Exercise/Conversion
Common Stock
2024-06-24+3,350→ 139,982 total
Footnotes (3)
- [F1]The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.
- [F2]Each RSU represents a contingent right to receive one share of the Company's common stock.
- [F3]RSUs granted on June 22, 2023, in connection with the Reporting Person's service as a non-employee director as of the Company's 2023 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.
Documents
Issuer
Tarsus Pharmaceuticals, Inc.
CIK 0001819790
Entity typeother
Related Parties
1- filerCIK 0001228684
Filing Metadata
- Form type
- 4
- Filed
- Jun 24, 8:00 PM ET
- Accepted
- Jun 25, 6:25 PM ET
- Size
- 7.2 KB